OSCR

Impact of Apolipoprotein E4 on blood-brain barrier integrity in target replacement murine models: a systematic review and meta-analysis.

Overview

Authors: Krystal K Laing1,2,3, Nela Fialova1,2,3, Joanna Wardlaw1,2,3, Axel Montagne1,2,3
  1. UK Dementia Research Institute at the University of Edinburgh, 49 Little France Crescent, Edinburgh, EH16 4SB UK
  2. UK Dementia Research Institute Centre for Vascular Dementia Research, British Heart Foundation, University of Edinburgh, Edinburgh, UK
  3. Institute for Neuroscience and Cardiovascular Research (INCR), University of Edinburgh, Chancellor’s Building, Edinburgh, UK
Institutions: British Heart Foundation (United Kingdom); UK Dementia Research Institute (United Kingdom); University of Edinburgh (United Kingdom)
Journal: Alzheimer's research & therapy, volume 18, issue 1, article 119
Dates: received 2 November 2025; accepted 14 March 2026; published online 7 May 2026
Type: Review · Language: English
License: CC BY
Identifiers: DOI 10.1186/s13195-026-02018-3 · PMID 42098772 · PMCID PMC13195987 · OpenAlex W7160525975
Open access: gold, a free copy (OpenAlex)
Status: code on request (how the code is found and verified)
Categories: mouse (organism), Alzheimer's / dementia (population), stroke (population), clinical / translational (subfield)
Methods: Statistics
Keywords: Apolipoprotein E4, Blood–brain barrier, Cerebral blood flow, Vascular dysfunction, Alzheimer’s disease, Systematic review, Meta-analysis
MeSH: Apolipoprotein E4*, Blood-Brain Barrier*, Alzheimer Disease, Animals, Cerebrovascular Circulation, Disease Models, Animal, Mice, Mice, Transgenic (* major topic)
Topic: Alzheimer's disease research and treatments (Cellular and Molecular Neuroscience, Neuroscience), according to OpenAlex
Funding: Wellcome Trust (110002)
Citations: not cited yet (Europe PMC); 69 references in the paper

Abstract

Background: The E4 variant of Apolipoprotein E (APOE) is a primary genetic susceptibility risk factor for late-onset Alzheimer’s disease and has been implicated in cerebrovascular dysfunction. Preclinical mouse models are widely used to study APOE4, but cohesive understanding of APOE’s role is still inconsistent and lacking. The aim of this study was to systematically review and synthesise evidence from preclinical mouse studies assessing APOE4 related effects on blood-brain barrier (BBB) integrity, vascular morphology and cerebral blood flow (CBF).

Main: A systematic search of MEDLINE, Embase, Scopus, and Web of Science was conducted (March-April 2025). Eligible studies included transgenic APOE-targeted replacement or knock-in mice reporting vascular outcomes (cerebral blood flow, blood brain barrier permeability, vascular measures). Risk of bias was assessed using SYRCLE and reporting quality with CAMARADES. Random-effects meta-analyses were conducted (where sufficient data was available), otherwise findings were narratively synthesised. Eighteen studies met inclusion. Outcome measures varied widely, including diverse approaches to CBF measurement (e.g. arterial spin labelling, autoradiography, DSC-MRI), immunohistochemical measures (e.g. collagen-IV, laminin, CD31), and diverse approaches to measurement of BBB leakage (e.g. fibronectin, fibrinogen, gadolinium-based ktrans). Seven studies contributed to meta-analysis: APOE4 mice showed a consistent reduction in CBF associated with APOE4 genotype (SMD = -2.87, 95% CI: -5.14 to -0.604, df = 2.66), and a negative non-significant trend towards reduced vascular morphology expression. Narrative synthesis identified three key mechanistic pathways linking APOE4 to vascular dysfunction: (i) insulin resistance and PI3K/AKT-mTOR signalling, (ii) Cyclophilin A–NFκB–MMP9 activation, and (iii) occludin/ECM remodelling. Risk of bias assessment revealed frequent shortcomings in randomisation, blinding, and sample size justification.

Conclusions: Preclinical evidence demonstrates that APOE4 drives alterations in vascular functioning primarily through involvement with pathways related to vascular metabolism, ECM remodelling and BBB leakage. However, heterogeneity in the model (e.g. age, sex, techniques), restricts direct comparability across studies. As such, standardisation or clarification of methodological approaches are necessary for rigorous assessment in the future.

Supplementary Information: The online version contains supplementary material available at 10.1186/s13195-026-02018-3.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

Datasets cited

Data availability

All data generated or analysed during this study are included in this article and its supplementary information files. The extracted dataset and analysis code that support the findings are available from the corresponding author on reasonable request. The full database search strategies have been deposited on searchRxiv (DOI: 10.1079/searchRxiv.2025.01124). The review protocol was registered with PROSPERO (CRD420251010665): (https://www.crd.york.ac.uk/PROSPERO/view/CRD420251010665).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 4 authors, 7 keywords, 8 MeSH terms, 1 funder, 66 references.

Cite

This paper

Laing, K. K., Fialova, N., Wardlaw, J., & Montagne, A. (2026). Impact of Apolipoprotein E4 on blood-brain barrier integrity in target replacement murine models: a systematic review and meta-analysis. Alzheimer's research & therapy, 18(1), 119. https://doi.org/10.1186/s13195-026-02018-3

BibTeX

@article{laing2026impact,
author = {Laing, Krystal K and Fialova, Nela and Wardlaw, Joanna and Montagne, Axel},
title = {{Impact of Apolipoprotein E4 on blood-brain barrier integrity in target replacement murine models: a systematic review and meta-analysis}},
journal = {Alzheimer's research \& therapy},
year = {2026},
month = may,
volume = {18},
number = {1},
pages = {119},
publisher = {BMC},
issn = {1758-9193},
doi = {10.1186/s13195-026-02018-3},
url = {https://doi.org/10.1186/s13195-026-02018-3},
pmid = {42098772},
pmcid = {PMC13195987}
}

RIS

TY - JOUR
AU - Laing, Krystal K
AU - Fialova, Nela
AU - Wardlaw, Joanna
AU - Montagne, Axel
TI - Impact of Apolipoprotein E4 on blood-brain barrier integrity in target replacement murine models: a systematic review and meta-analysis
T2 - Alzheimer's research & therapy
J2 - Alzheimers Res Ther
PY - 2026
DA - 2026/05/07
VL - 18
IS - 1
SP - 119
SN - 1758-9193
PB - BMC
DO - 10.1186/s13195-026-02018-3
UR - https://doi.org/10.1186/s13195-026-02018-3
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s13195-026-02018-3",
"type": "article-journal",
"title": "Impact of Apolipoprotein E4 on blood-brain barrier integrity in target replacement murine models: a systematic review and meta-analysis",
"container-title": "Alzheimer's research & therapy",
"author": [
{
"family": "Laing",
"given": "Krystal K"
},
{
"family": "Fialova",
"given": "Nela"
},
{
"family": "Wardlaw",
"given": "Joanna"
},
{
"family": "Montagne",
"given": "Axel"
}
],
"container-title-short": "Alzheimers Res Ther",
"volume": "18",
"issue": "1",
"page": "119",
"DOI": "10.1186/s13195-026-02018-3",
"PMID": "42098772",
"PMCID": "PMC13195987",
"ISSN": "1758-9193",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s13195-026-02018-3",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
7
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.21203/rs.3.rs-8011437/v1
Impact of Apolipoprotein E4 on Blood-Brain Barrier Integrity in Target Replacement Murine Models: A Systematic Review and Meta-Analysis
Journal: Research Square (preprint)
In common: Alzheimer's / dementia, clinical / translational, mouse, 41 references
[2] doi:10.1186/s13024-022-00566-4
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.
Journal: Molecular neurodegeneration
In common: Alzheimer's / dementia, 12 references
[3] doi:10.1038/s42003-025-07585-z [code]
APOE4 and sedentary lifestyle synergistically impair neurovascular function in the visual cortex of awake mice.
Journal: Communications biology
In common: stroke, Alzheimer's / dementia, mouse, 9 references
[4] doi:10.1186/s13195-026-01960-6
Proof-of-concept study: APOE4 brain endothelial cells as a phenotypic compound screen.
Journal: Alzheimer's research & therapy
In common: Alzheimer's / dementia, mouse, 8 references
[5] doi:10.1084/jem.20221137
A "multi-omics" analysis of blood-brain barrier and synaptic dysfunction in APOE4 mice.
Journal: The Journal of experimental medicine
In common: Alzheimer's / dementia, mouse, 8 references
[6] doi:10.3389/fnins.2025.1629830
<i>APOE4-APP</i> interactions exert early influences on cerebrovascular structure and function: implications for Alzheimer's disease.
Journal: Frontiers in neuroscience
In common: stroke, Alzheimer's / dementia, mouse, 7 references
[7] doi:10.64898/2026.03.01.708815
APOE4 Genotype is Associated with Reduced Cortical VEGFR2 ( <i>KDR</i> ) Transcript Levels Independent of Endothelial Abundance: An AMP-AD RNA-seq Pilot Study
Journal: bioRxiv (preprint)
In common: Alzheimer's / dementia, 6 references
[8] doi:10.3389/fnagi.2023.1088140
Alzheimer's disease pathology: pathways between chronic vascular risk factors and blood-brain barrier dysfunction in a cohort of patients with different types of dementia.
Journal: Frontiers in aging neuroscience
In common: Alzheimer's / dementia, clinical / translational, 6 references
[9] doi:10.1186/s12974-026-03888-y
Integrated imaging and molecular profiling reveals APOE4-associated neurovascular and glial disruptions in young adult mice.
Journal: Journal of neuroinflammation
In common: Alzheimer's / dementia, mouse, 6 references
[10] doi:10.1038/s43856-025-00942-3 [code]
Protection against APOE4-associated phenotypes with the longevity-promoting intervention 17α-estradiol in middle-aged male mice.
Journal: Communications medicine
In common: Alzheimer's / dementia, clinical / translational, mouse, 4 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.